Recent SEC Filings
| Entity | Filing | Filed On |
|---|---|---|
| Erasca Inc | ARCH VENTURE FUND X, L.P. - ERASCA, INC. -- SCH 13G/A(#1E) | 14 Nov 2024 |
| Erasca Inc | SC 13G/A | 14 Nov 2024 |
| Epsilon Energy Ltd | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 14 Nov 2024 |
| Equillium Inc | SC 13G/A | 14 Nov 2024 |
| Entegris Inc | SC 13G/A | 14 Nov 2024 |
| Ensign Group Inc | SC 13G/A | 14 Nov 2024 |
| enVVeno Medical Corp | SC 13G/A | 14 Nov 2024 |
| Valaris Ltd | ORBIS INVESTMENT MANAGEMENT LIMITED | 14 Nov 2024 |
| Energy Recovery Inc | SC 13G/A | 14 Nov 2024 |
| Encompass Health Corp | SC 13G/A | 14 Nov 2024 |
| Endeavor Group Holdings Inc | SC 13G/A | 14 Nov 2024 |
| Enanta Pharmaceuticals Inc | SC 13G/A | 14 Nov 2024 |
| EMCORE Corp | SC 13G/A | 14 Nov 2024 |
| Ellomay Capital Ltd | SC 13G/A | 14 Nov 2024 |
| Skye Bioscience Inc | JANUS CLOSEOUT | 14 Nov 2024 |
| Skye Bioscience Inc | AMENDMENT TO FORM SC 13G | 14 Nov 2024 |
| Eli Lilly and Co | SC 13G/A | 14 Nov 2024 |
| Revvity Inc | SCHEDULE 13G/A, (AMENDMENT NO. 2) | 14 Nov 2024 |
| Revvity Inc | SC 13G/A | 14 Nov 2024 |
| Element Solutions Inc | SC 13G/A | 14 Nov 2024 |
